查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1924715

非穿戴式劑量測定市場按技術、輻射類型、應用、最終用戶和分銷管道分類－2026-2032年全球預測

Non-wearable Dosimetry Market by Technology, Radiation Type, Application, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2025 年非穿戴式劑量測定市值為 2.0475 億美元，預計到 2026 年將成長至 2.2536 億美元，年複合成長率為 9.18%，到 2032 年將達到 3.7868 億美元。

關鍵市場統計數據
基準年 2025 2.0475億美元
預計年份：2026年 2.2536億美元
預測年份 2032 3.7868億美元
複合年成長率 (%) 9.18%

本文簡要概述了非穿戴式劑量測定設備在營運和監管方面的重要性，以及影響其採購和實施的不斷變化的期望。

非穿戴式劑量測定技術在輻射防護、環境監測和工業安全領域中佔有重要的地位。用於監測環境或區域輻射水平的設備和系統，包括固定式檢測器以及可部署的被動式和主動式感測器，是職業安全計畫、環境監測和監管合規機制的基礎組成部分。從醫院到核能設施，相關人員都依賴可靠且經過認證的測量解決方案來保障員工安全和公眾健康。

數位化融合、檢測器材料的進步以及監管趨同正在從根本上重塑產品設計、服務模式和採購政策。

非穿戴式劑量測定領域正經歷變革性的轉變，這主要得益於數位整合、材料創新以及日益嚴格的監管。數位化正在從基本數據記錄發展到連網檢測器，並具備遠端監控、邊緣分析和自動警報功能，使設施操作人員能夠快速且準確地應對異常情況。檢測器材料和訊號處理技術的進步提高了靈敏度並延長了使用壽命，而小型化和加固化則拓展了在嚴苛工業環境中的安裝選擇。

新關稅對供應鏈韌性、籌資策略和製造決策的連鎖反應，正在促使產業優先事項和夥伴關係關係進行重塑。

2025年推出的關稅和貿易措施為非穿戴式劑量測定設備的供應鏈和採購決策帶來了新的複雜性。關鍵零件和成品的關稅提高了採購風險的可見度，促使許多企業重新評估供應商關係和總到岸成本，而不僅僅關注單位成本。隨著採購團隊考慮各種替代方案，在可行的情況下，回流和近岸外包方案正受到越來越多的關注，製造商也在考慮區域組裝和零件採購，以降低關稅風險並縮短前置作業時間。

多維細分分析揭示了技術選擇、應用需求、最終用戶畫像、輻射類型和分銷管道如何驅動採購和部署趨勢

透過了解技術、應用、最終用戶、輻射類型和分銷管道等方面的細分，可以多維度地了解需求促進因素和供應商定位。從技術角度來看，市場可分為主動式和被動式系統。主動式系統主要由電子劑量計組成，可實現即時監測和網路警報；而被動式系統則包括膠片劑量計、OSL 和 TLD 等，這些系統具有成熟可靠、維護成本低的記錄方式，是需要長期劑量累積時的首選。每種技術方案都面臨獨特的校準、維護和資料處理挑戰，這些挑戰會影響整體擁有成本以及不同運行環境的適用性。

美洲、歐洲、中東和非洲以及亞太地區的區域趨勢和監管重點將影響非穿戴式劑量測定技術的應用模式、服務需求和供應鏈策略。

區域趨勢在非穿戴式劑量測定設備的採用模式、法規要求和供應鏈配置中發揮關鍵作用。在美洲，成熟的醫療保健基礎設施、工業安全計畫和環境監測措施共同影響著市場需求，從而對歷史悠久的被動式系統和日益數位化化的主動式監測解決方案都產生了穩定的需求。法規結構強調可追溯性和校準合規性，這推動了對提供本地服務網路和快速回應技術支援的供應商的需求。

透過技術可靠性、全生命週期服務、通路夥伴關係和策略聯盟，確保設備性能和客戶連續性，從而獲得競爭優勢。

非穿戴式劑量計市場的競爭趨勢主要集中在企業能否將卓越的技術、可靠的服務交付和完善的品管系統結合。主要企業透過持續投資於檢測器精度、校準服務以及支援集中監測和資料存檔的軟體平台來脫穎而出。能夠提供從安裝、校準到韌體維護和符合審核要求的報告等全生命週期支援的企業，正贏得安全關鍵型終端用戶的更多信任。

領導企業增強供應鏈韌性、拓展服務主導產品以及調整產品架構以適應不斷變化的監管和營運需求的實用策略

為了應對當前複雜的市場環境並獲取策略價值，產業領導者應採取協調一致的營運、商業和技術策略。優先考慮價值鏈多元化和情境規劃，以降低關稅引發的供應中斷風險，並確保關鍵零件的持續供應。同時，透過靈活的製造策略（例如區域組裝和策略供應商合作）來增強採購韌性，從而縮短前置作業時間並提供本地化的售後服務。

採用系統性透明的調查方法，結合相關人員訪談、標準分析和三角驗證綜合分析，得出對市場動態的檢驗評估。

本執行摘要的研究結合了定性和定量方法，以深入了解市場動態。主要研究包括對各類相關人員進行結構化訪談，這些利害關係人包括採購人員、輻射安全負責人、技術服務提供者、儀器工程師和監管專家。這些訪談提供了關於操作要求、決策標準以及安裝、校準和維護方面的實際考慮因素的第一手觀點。

綜合分析結果凸顯了整合技術和服務產品、供應鏈韌性以及合規性為何決定著市場成功。

總之，非穿戴式劑量學領域正處於一個轉折點，其特點是技術融合、供應鏈重組以及日益嚴格的監管要求。包括環境監測、醫療保健、工業安全和核能營運在內的各個領域的組織都在優先部署能夠提供精確測量、審核記錄和可靠服務支援的系統。主動電子監測與成熟的被動記錄方法相結合，為眾多終端用戶提供了一條可行的途徑，以平衡即時可見性需求和長期劑量記錄要求。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 非穿戴式劑量測定市場（依技術分類）

  • 活動類型
  • 被動的
    • 電影徽章
    • OSL
    • TLD

9. 非穿戴式劑量測定市場（依輻射類型分類）

  • BETA射線
  • 中子
  • X光和伽瑪射線

第10章 非穿戴式劑量測定市場（依應用分類）

  • 環境
  • 工業的
  • 醫療保健
  • 核能發電

第11章 非穿戴式劑量測定市場（依最終用戶分類）

  • 診斷中心
  • 醫院
  • 工業安全
  • 核能發電廠
  • 研究所

第12章 非穿戴式劑量測定市場（依分銷通路分類）

  • 離線
  • 線上

13. 按地區分類的非穿戴式劑量測定市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 非穿戴式劑量測定市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 各國非穿戴式劑量測定市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國非穿戴式劑量測定市場

第17章：中國非穿戴式劑量測定市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • AMETEK, Inc.
  • ATOMTEX Co., Ltd.
  • Bar-Ray Products, Inc.
  • Berkeley Nucleonics Corp.
  • Blackline Safety Corp.
  • Electronic & Engineering Co. P. Ltd.
  • Fuji Electric Co., Ltd.
  • General Atomics
  • Honeywell Automation India Ltd.
  • IBA Dosimetry GmbH
  • Landauer, Inc.
  • Ludlum Measurements, Inc.
  • Mirion Technologies, Inc.
  • Narda Safety Test Solutions GmbH
  • Nucleonix Systems Private Limited
  • PLA Electro Appliances Private Limited
  • PTW Freiburg GmbH
  • Saint-Gobain SA
  • Senergy Intellution Pvt. Ltd.
  • Thermo Fisher Scientific Inc.
Product Code: MRR-7A380DA7C448

The Non-wearable Dosimetry Market was valued at USD 204.75 million in 2025 and is projected to grow to USD 225.36 million in 2026, with a CAGR of 9.18%, reaching USD 378.68 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 204.75 million
Estimated Year [2026] USD 225.36 million
Forecast Year [2032] USD 378.68 million
CAGR (%) 9.18%

A concise framing of the operational and regulatory importance of non-wearable dosimetry devices and the evolving expectations shaping procurement and deployment

Non-wearable dosimetry occupies a critical niche at the intersection of radiation protection, environmental monitoring, and industrial safety. Devices and systems that monitor ambient or area radiation levels, including fixed detectors and deployable passive or active sensors, serve as foundational elements for occupational safety programs, environmental surveillance, and regulatory compliance regimes. Stakeholders from hospitals to nuclear facilities depend on reliable, certified measurement solutions to ensure worker safety and protect public health.

Recent years have seen elevated attention on instrumentation accuracy, lifecycle support, and data integrity as regulators and customers demand traceable records and auditable monitoring practices. Concurrently, advances in electronics, materials science, and data analytics are reshaping how area dosimetry is deployed and managed, creating new expectations for interoperability, remote diagnostics, and predictive maintenance. Supply chain resilience and manufacturing footprint considerations now factor heavily into procurement decisions as organizations seek continuity in critical safety infrastructure.

This introduction establishes the operational context for non-wearable dosimetry and frames the subsequent sections, which examine technological transitions, tariff-driven supply chain impacts, segmentation nuances, regional patterns, competitive dynamics, and pragmatic recommendations for leaders navigating an increasingly complex landscape.

How digital integration, detector material advances, and regulatory convergence are fundamentally reshaping product design, service models, and procurement preferences

The landscape of non-wearable dosimetry is undergoing transformative shifts driven by digital integration, materials innovation, and heightened regulatory rigor. Digitalization has moved beyond basic data logging to include networked detectors that support remote monitoring, edge analytics, and automated alerting, enabling facility operators to act on anomalies with speed and precision. Advances in detector materials and signal processing have improved sensitivity and extended operational lifetimes, while miniaturization and ruggedization have expanded deployment options in harsh industrial environments.

At the same time, regulatory frameworks and accreditation expectations are converging on clearer traceability, standardized calibration protocols, and requirements for long-term data retention. These pressures are incentivizing vendors to deliver not only hardware but integrated software services and lifecycle management solutions that include calibration, firmware updates, and documentation support. The emergence of cloud-hosted data solutions and secure telemetry has enabled centralized monitoring across distributed sites, but it has also raised cybersecurity and data governance considerations that organizations must address.

Transitioning to these new capabilities requires coordinated investments in interoperability, workforce training, and procurement strategies that favor modular, service-oriented offerings. As stakeholders prioritize systems that reduce operational friction and provide auditable records, vendors who pair technical performance with robust service models will gain preference in procurement conversations.

The ripple effects of new tariffs on supply chain resilience, procurement strategies, and manufacturing decisions that are reshaping industry priorities and partnerships

The introduction of tariffs and trade measures in 2025 has created a new layer of complexity for non-wearable dosimetry supply chains and procurement decisions. Tariffs on key components and finished instruments have amplified the visibility of sourcing risk, prompting many organizations to reassess supplier relationships and total landed cost rather than focusing solely on unit price. As procurement teams evaluate alternatives, reshoring and nearshoring options have gained traction where feasible, with manufacturers considering regional assembly or component sourcing to mitigate tariff exposure and shorten lead times.

At the buyer level, increased cost volatility has elevated the importance of contract flexibility and inventory management strategies. Long-term maintenance agreements and multi-year calibration contracts are being structured to protect service continuity and cost predictability. For vendors, tariffs have shifted competitive dynamics: those able to adapt manufacturing footprints, consolidate component suppliers, or re-platform products to use locally sourced parts are better positioned to preserve margins and customer relationships.

Additionally, the tariff environment has underscored the value of transparency across the supply chain. Buyers are demanding clearer provenance data and more rigorous supplier audits, while risk-aware organizations are prioritizing partners with diversified sourcing and robust contingency plans. Ultimately, tariffs are accelerating strategic shifts that emphasize resilience, supplier partnerships, and operational agility across the ecosystem.

Multidimensional segmentation insights revealing how technology choices, application needs, end-user profiles, radiation types, and distribution channels drive procurement and deployment dynamics

Understanding segmentation across technology, application, end user, radiation type, and distribution channel provides a multidimensional view of demand drivers and supplier positioning. Based on technology, the market is observed across active and passive systems; active systems are primarily composed of electronic dosimeters that enable real-time monitoring and networked alerts, while passive options include film badge, OSL, and TLD formats that offer proven, low-maintenance archival records and are favored where long-term dose integration is required. Each technology path has distinct calibration, maintenance, and data-handling implications that influence total cost of ownership and suitability for different operating environments.

Based on application, deployments cluster in environmental surveillance, industrial monitoring, medical imaging and therapy environments, and nuclear power operations, with each application imposing unique accuracy, response time, and certification demands. Based on end user, typical buyers include diagnostic centers, hospitals, industrial safety teams, nuclear power plants, and research laboratories; procurement decisions in these settings are shaped by organizational risk tolerance, regulatory exposure, and existing service ecosystems. Based on radiation type, detectors are optimized for beta, neutron, or X ray and gamma exposures, with sensor selection and calibration protocols tailored to the energy spectrum and expected dose profiles of the operating environment. Based on distribution channel, supply pathways include direct sales, distributor networks, and online channels, each offering differing degrees of technical support, logistics capability, and aftermarket service.

Taken together, these segmentation dimensions reveal that successful market engagement requires aligning product capability and commercial model to the specific technical requirements and procurement practices of each buyer cohort, and that cross-segmentation strategies-such as combining electronic monitoring with passive archival options-can address complex operational needs while opening new revenue and service opportunities.

Regional dynamics and regulatory priorities across the Americas, Europe Middle East & Africa, and Asia-Pacific that determine adoption patterns, service needs, and supply chain strategies

Regional dynamics play a pivotal role in adoption patterns, regulatory expectations, and supply chain configurations for non-wearable dosimetry. In the Americas, demand is influenced by a mixture of mature healthcare infrastructure, industrial safety programs, and environmental monitoring initiatives, creating steady requirements for both long-established passive systems and increasingly digital active monitoring solutions. Regulatory frameworks emphasize traceability and calibration compliance, which in turn drives demand for vendors offering local service footprints and rapid technical support.

In Europe, Middle East & Africa, regulatory harmonization across jurisdictions and a strong focus on nuclear safety and medical device conformity shape procurement choices, while market diversity requires adaptable distribution strategies and multilingual technical support. In particular, regions with expanding nuclear or industrial sectors present opportunities for integrated surveillance systems that combine fixed detectors and centralized data platforms. The Asia-Pacific region exhibits a broad spectrum of demand dynamics, from advanced research and healthcare facilities in some markets to rapidly industrializing economies in others, which fuels a wide range of requirements from high-precision instruments to cost-effective archival solutions. Manufacturing hubs and component suppliers in the region also influence global supply chains, making Asia-Pacific central to sourcing and production strategies.

Across all regions, the combination of regulatory scrutiny, infrastructure investment, and local service capabilities determines how quickly new technologies are adopted and which commercial models succeed in the market.

Competitive advantage driven by technical reliability, lifecycle services, channel partnerships, and strategic alliances that ensure instrument performance and customer continuity

Competitive dynamics in the non-wearable dosimetry market center on the ability of companies to combine technical excellence with dependable service offerings and robust quality systems. Leading providers differentiate through sustained investment in detector accuracy, calibration services, and software platforms that enable centralized monitoring and data archival. Companies that can demonstrate end-to-end lifecycle support - from installation and calibration to firmware maintenance and audit-ready reporting - earn higher levels of trust among safety-critical end users.

Strategic partnerships and channel strategies are also important differentiators. Firms that cultivate deep relationships with distributors and service partners expand geographic reach and ensure continuity of after-sales support. In parallel, organizations that invest in training and certification programs for customers and resellers strengthen their value proposition and reduce implementation friction. Intellectual property in sensor design, signal processing algorithms, and calibration methodologies helps protect competitive advantage, but practical market leadership often flows from reliability in delivery and responsiveness in customer support.

Mergers, targeted acquisitions, and alliance building are recurring themes as companies seek to fill capability gaps, add regional service footprints, or accelerate software and data analytics offerings. Ultimately, the market rewards those who balance technical credibility with accessible service models and demonstrable operational continuity.

Action oriented strategies for leaders to bolster supply chain resilience, expand service led offerings, and align product architectures with evolving regulatory and operational needs

To navigate current complexities and capture strategic value, industry leaders should pursue a coordinated set of operational, commercial, and technical actions. Prioritize supply chain diversification and scenario planning to reduce exposure to tariff-driven disruption and to maintain continuity of critical components. Complement sourcing resilience with flexible manufacturing strategies, including regional assembly or strategic supplier partnerships, to contain lead times and support localized after-sales service.

Invest in modular product architectures that enable seamless integration of electronic monitoring systems with passive archival detectors, thereby offering customers flexible solutions that meet both real-time alerting and long-term compliance needs. Strengthen service portfolios by bundling calibration, training, and remote monitoring as subscription offerings that create predictable revenue streams and deepen customer relationships. Emphasize interoperability and open data standards to facilitate integration into facility management and regulatory reporting workflows, while instituting robust cybersecurity and data governance practices.

Engage proactively with regulators and industry consortia to shape emerging standards and to ensure that new product innovations meet certification pathways efficiently. Finally, upskill field service teams and customer support functions to deliver consultative implementation assistance, because operational reliability and rapid responsiveness remain the decisive factors for end users when selecting a vendor.

A methodical and transparent research approach combining stakeholder interviews, standards analysis, and triangulated synthesis to produce a validated assessment of market dynamics

The research underpinning this executive summary combines qualitative and quantitative approaches to produce a validated view of market dynamics. Primary research included structured interviews with a cross-section of stakeholders: procurement leaders, radiation safety officers, technical service providers, instrumentation engineers, and regulatory specialists. These interviews provided firsthand perspectives on operational requirements, decision criteria, and practical considerations around installation, calibration, and maintenance.

Secondary research drew on publicly available regulatory documents, standards publications, technical white papers, and manufacturer product literature to map technology capabilities, certification expectations, and historical performance characteristics. Data and insights were triangulated through cross-validation between primary inputs and authoritative secondary sources to ensure consistency and to identify contrasting viewpoints. Segmentation logic was developed by mapping technology attributes against application use cases and end-user procurement behavior, while regional analysis incorporated policy drivers and infrastructure considerations.

Methodological rigor was applied through iterative review cycles with subject-matter experts and by documenting assumptions and limitations inherent in qualitative synthesis. The goal was to deliver a transparent, reproducible assessment that supports confident decision-making while acknowledging areas where ongoing monitoring or supplemental primary research would reduce residual uncertainty.

Consolidated findings emphasizing why integrated technology-service offerings, supply chain resilience, and regulatory alignment will define success in the market

In conclusion, the non-wearable dosimetry landscape is at an inflection point defined by technological convergence, supply chain realignment, and intensifying regulatory expectations. Organizations across environmental monitoring, healthcare, industrial safety, and nuclear operations are prioritizing systems that deliver accurate measurements, auditable records, and dependable service support. The interplay of active electronic monitoring and established passive archival methods offers a pragmatic path for many end users to reconcile demands for real-time awareness with requirements for long-term dose documentation.

Tariff pressures have foregrounded supply chain resilience and total cost considerations, prompting both buyers and sellers to rethink sourcing, manufacturing footprints, and contractual structures. Regionally differentiated adoption patterns underscore the importance of local service presence and regulatory alignment, while competitive advantages accrue to companies that combine technical rigor with lifecycle service models. For decision-makers, the pragmatic priorities are clear: invest in interoperability and data governance, secure diversified supply options, and align commercial models to support predictable maintenance and compliance.

These themes point toward a market that will favor flexible, service-oriented offerings and partners capable of delivering operational continuity. For stakeholders preparing procurement or investment strategies, focusing on these areas will improve readiness and reduce exposure to the key risks identified across the analysis.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Non-wearable Dosimetry Market, by Technology

  • 8.1. Active
  • 8.2. Passive
    • 8.2.1. Film Badge
    • 8.2.2. Osl
    • 8.2.3. Tld

9. Non-wearable Dosimetry Market, by Radiation Type

  • 9.1. Beta
  • 9.2. Neutron
  • 9.3. X Ray & Gamma

10. Non-wearable Dosimetry Market, by Application

  • 10.1. Environmental
  • 10.2. Industrial
  • 10.3. Medical
  • 10.4. Nuclear Power

11. Non-wearable Dosimetry Market, by End User

  • 11.1. Diagnostic Centers
  • 11.2. Hospitals
  • 11.3. Industrial Safety
  • 11.4. Nuclear Power Plants
  • 11.5. Research Laboratories

12. Non-wearable Dosimetry Market, by Distribution Channel

  • 12.1. Offline
  • 12.2. Online

13. Non-wearable Dosimetry Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Non-wearable Dosimetry Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Non-wearable Dosimetry Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Non-wearable Dosimetry Market

17. China Non-wearable Dosimetry Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. AMETEK, Inc.
  • 18.6. ATOMTEX Co., Ltd.
  • 18.7. Bar-Ray Products, Inc.
  • 18.8. Berkeley Nucleonics Corp.
  • 18.9. Blackline Safety Corp.
  • 18.10. Electronic & Engineering Co. P. Ltd.
  • 18.11. Fuji Electric Co., Ltd.
  • 18.12. General Atomics
  • 18.13. Honeywell Automation India Ltd.
  • 18.14. IBA Dosimetry GmbH
  • 18.15. Landauer, Inc.
  • 18.16. Ludlum Measurements, Inc.
  • 18.17. Mirion Technologies, Inc.
  • 18.18. Narda Safety Test Solutions GmbH
  • 18.19. Nucleonix Systems Private Limited
  • 18.20. PLA Electro Appliances Private Limited
  • 18.21. PTW Freiburg GmbH
  • 18.22. Saint-Gobain S.A.
  • 18.23. Senergy Intellution Pvt. Ltd.
  • 18.24. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL NON-WEARABLE DOSIMETRY MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL NON-WEARABLE DOSIMETRY MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY RADIATION TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES NON-WEARABLE DOSIMETRY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA NON-WEARABLE DOSIMETRY MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY ACTIVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY ACTIVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY ACTIVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY PASSIVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY PASSIVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY PASSIVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY PASSIVE, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY FILM BADGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY FILM BADGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY FILM BADGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY OSL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY OSL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY OSL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY TLD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY TLD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY TLD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY RADIATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY BETA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY BETA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY BETA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY NEUTRON, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY NEUTRON, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY NEUTRON, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY X RAY & GAMMA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY X RAY & GAMMA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY X RAY & GAMMA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY ENVIRONMENTAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY ENVIRONMENTAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY ENVIRONMENTAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY INDUSTRIAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY INDUSTRIAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY INDUSTRIAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY MEDICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY MEDICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY MEDICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY NUCLEAR POWER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY NUCLEAR POWER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY NUCLEAR POWER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY INDUSTRIAL SAFETY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY INDUSTRIAL SAFETY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY INDUSTRIAL SAFETY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY NUCLEAR POWER PLANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY NUCLEAR POWER PLANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY NUCLEAR POWER PLANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY RESEARCH LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY RESEARCH LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. AMERICAS NON-WEARABLE DOSIMETRY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 67. AMERICAS NON-WEARABLE DOSIMETRY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 68. AMERICAS NON-WEARABLE DOSIMETRY MARKET SIZE, BY PASSIVE, 2018-2032 (USD MILLION)
  • TABLE 69. AMERICAS NON-WEARABLE DOSIMETRY MARKET SIZE, BY RADIATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 70. AMERICAS NON-WEARABLE DOSIMETRY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 71. AMERICAS NON-WEARABLE DOSIMETRY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 72. AMERICAS NON-WEARABLE DOSIMETRY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 73. NORTH AMERICA NON-WEARABLE DOSIMETRY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. NORTH AMERICA NON-WEARABLE DOSIMETRY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 75. NORTH AMERICA NON-WEARABLE DOSIMETRY MARKET SIZE, BY PASSIVE, 2018-2032 (USD MILLION)
  • TABLE 76. NORTH AMERICA NON-WEARABLE DOSIMETRY MARKET SIZE, BY RADIATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 77. NORTH AMERICA NON-WEARABLE DOSIMETRY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 78. NORTH AMERICA NON-WEARABLE DOSIMETRY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA NON-WEARABLE DOSIMETRY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 80. LATIN AMERICA NON-WEARABLE DOSIMETRY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. LATIN AMERICA NON-WEARABLE DOSIMETRY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 82. LATIN AMERICA NON-WEARABLE DOSIMETRY MARKET SIZE, BY PASSIVE, 2018-2032 (USD MILLION)
  • TABLE 83. LATIN AMERICA NON-WEARABLE DOSIMETRY MARKET SIZE, BY RADIATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 84. LATIN AMERICA NON-WEARABLE DOSIMETRY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 85. LATIN AMERICA NON-WEARABLE DOSIMETRY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 86. LATIN AMERICA NON-WEARABLE DOSIMETRY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA NON-WEARABLE DOSIMETRY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA NON-WEARABLE DOSIMETRY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 89. EUROPE, MIDDLE EAST & AFRICA NON-WEARABLE DOSIMETRY MARKET SIZE, BY PASSIVE, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE, MIDDLE EAST & AFRICA NON-WEARABLE DOSIMETRY MARKET SIZE, BY RADIATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE, MIDDLE EAST & AFRICA NON-WEARABLE DOSIMETRY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE, MIDDLE EAST & AFRICA NON-WEARABLE DOSIMETRY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE, MIDDLE EAST & AFRICA NON-WEARABLE DOSIMETRY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE NON-WEARABLE DOSIMETRY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE NON-WEARABLE DOSIMETRY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE NON-WEARABLE DOSIMETRY MARKET SIZE, BY PASSIVE, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE NON-WEARABLE DOSIMETRY MARKET SIZE, BY RADIATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE NON-WEARABLE DOSIMETRY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE NON-WEARABLE DOSIMETRY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE NON-WEARABLE DOSIMETRY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 101. MIDDLE EAST NON-WEARABLE DOSIMETRY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. MIDDLE EAST NON-WEARABLE DOSIMETRY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 103. MIDDLE EAST NON-WEARABLE DOSIMETRY MARKET SIZE, BY PASSIVE, 2018-2032 (USD MILLION)
  • TABLE 104. MIDDLE EAST NON-WEARABLE DOSIMETRY MARKET SIZE, BY RADIATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 105. MIDDLE EAST NON-WEARABLE DOSIMETRY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 106. MIDDLE EAST NON-WEARABLE DOSIMETRY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 107. MIDDLE EAST NON-WEARABLE DOSIMETRY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 108. AFRICA NON-WEARABLE DOSIMETRY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. AFRICA NON-WEARABLE DOSIMETRY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 110. AFRICA NON-WEARABLE DOSIMETRY MARKET SIZE, BY PASSIVE, 2018-2032 (USD MILLION)
  • TABLE 111. AFRICA NON-WEARABLE DOSIMETRY MARKET SIZE, BY RADIATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. AFRICA NON-WEARABLE DOSIMETRY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 113. AFRICA NON-WEARABLE DOSIMETRY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 114. AFRICA NON-WEARABLE DOSIMETRY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC NON-WEARABLE DOSIMETRY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC NON-WEARABLE DOSIMETRY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC NON-WEARABLE DOSIMETRY MARKET SIZE, BY PASSIVE, 2018-2032 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC NON-WEARABLE DOSIMETRY MARKET SIZE, BY RADIATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC NON-WEARABLE DOSIMETRY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC NON-WEARABLE DOSIMETRY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC NON-WEARABLE DOSIMETRY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 123. ASEAN NON-WEARABLE DOSIMETRY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. ASEAN NON-WEARABLE DOSIMETRY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 125. ASEAN NON-WEARABLE DOSIMETRY MARKET SIZE, BY PASSIVE, 2018-2032 (USD MILLION)
  • TABLE 126. ASEAN NON-WEARABLE DOSIMETRY MARKET SIZE, BY RADIATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 127. ASEAN NON-WEARABLE DOSIMETRY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 128. ASEAN NON-WEARABLE DOSIMETRY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 129. ASEAN NON-WEARABLE DOSIMETRY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 130. GCC NON-WEARABLE DOSIMETRY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 131. GCC NON-WEARABLE DOSIMETRY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 132. GCC NON-WEARABLE DOSIMETRY MARKET SIZE, BY PASSIVE, 2018-2032 (USD MILLION)
  • TABLE 133. GCC NON-WEARABLE DOSIMETRY MARKET SIZE, BY RADIATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. GCC NON-WEARABLE DOSIMETRY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 135. GCC NON-WEARABLE DOSIMETRY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 136. GCC NON-WEARABLE DOSIMETRY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPEAN UNION NON-WEARABLE DOSIMETRY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPEAN UNION NON-WEARABLE DOSIMETRY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPEAN UNION NON-WEARABLE DOSIMETRY MARKET SIZE, BY PASSIVE, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPEAN UNION NON-WEARABLE DOSIMETRY MARKET SIZE, BY RADIATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPEAN UNION NON-WEARABLE DOSIMETRY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPEAN UNION NON-WEARABLE DOSIMETRY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPEAN UNION NON-WEARABLE DOSIMETRY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 144. BRICS NON-WEARABLE DOSIMETRY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. BRICS NON-WEARABLE DOSIMETRY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 146. BRICS NON-WEARABLE DOSIMETRY MARKET SIZE, BY PASSIVE, 2018-2032 (USD MILLION)
  • TABLE 147. BRICS NON-WEARABLE DOSIMETRY MARKET SIZE, BY RADIATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. BRICS NON-WEARABLE DOSIMETRY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 149. BRICS NON-WEARABLE DOSIMETRY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 150. BRICS NON-WEARABLE DOSIMETRY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 151. G7 NON-WEARABLE DOSIMETRY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 152. G7 NON-WEARABLE DOSIMETRY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 153. G7 NON-WEARABLE DOSIMETRY MARKET SIZE, BY PASSIVE, 2018-2032 (USD MILLION)
  • TABLE 154. G7 NON-WEARABLE DOSIMETRY MARKET SIZE, BY RADIATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 155. G7 NON-WEARABLE DOSIMETRY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 156. G7 NON-WEARABLE DOSIMETRY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 157. G7 NON-WEARABLE DOSIMETRY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 158. NATO NON-WEARABLE DOSIMETRY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 159. NATO NON-WEARABLE DOSIMETRY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 160. NATO NON-WEARABLE DOSIMETRY MARKET SIZE, BY PASSIVE, 2018-2032 (USD MILLION)
  • TABLE 161. NATO NON-WEARABLE DOSIMETRY MARKET SIZE, BY RADIATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. NATO NON-WEARABLE DOSIMETRY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 163. NATO NON-WEARABLE DOSIMETRY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 164. NATO NON-WEARABLE DOSIMETRY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 165. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 166. UNITED STATES NON-WEARABLE DOSIMETRY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 167. UNITED STATES NON-WEARABLE DOSIMETRY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 168. UNITED STATES NON-WEARABLE DOSIMETRY MARKET SIZE, BY PASSIVE, 2018-2032 (USD MILLION)
  • TABLE 169. UNITED STATES NON-WEARABLE DOSIMETRY MARKET SIZE, BY RADIATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. UNITED STATES NON-WEARABLE DOSIMETRY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 171. UNITED STATES NON-WEARABLE DOSIMETRY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 172. UNITED STATES NON-WEARABLE DOSIMETRY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 173. CHINA NON-WEARABLE DOSIMETRY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 174. CHINA NON-WEARABLE DOSIMETRY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 175. CHINA NON-WEARABLE DOSIMETRY MARKET SIZE, BY PASSIVE, 2018-2032 (USD MILLION)
  • TABLE 176. CHINA NON-WEARABLE DOSIMETRY MARKET SIZE, BY RADIATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 177. CHINA NON-WEARABLE DOSIMETRY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 178. CHINA NON-WEARABLE DOSIMETRY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 179. CHINA NON-WEARABLE DOSIMETRY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)